![Today's pickup includes 20x 1mg Teva Klonopin. 18x .5 Solco/Qualitest Klonopin. 3x 30mg IR adderall by Teva. And 9x 20mg Adderall IR by Teva. N 17x 2mg Breckenridge pharma bars. 😳🤙🏻💯🤷♂️🤷♂️🤦♂️🙏🏻🙏🏻🙏🏻🙏🏻✌️✌️ : Today's pickup includes 20x 1mg Teva Klonopin. 18x .5 Solco/Qualitest Klonopin. 3x 30mg IR adderall by Teva. And 9x 20mg Adderall IR by Teva. N 17x 2mg Breckenridge pharma bars. 😳🤙🏻💯🤷♂️🤷♂️🤦♂️🙏🏻🙏🏻🙏🏻🙏🏻✌️✌️ :](https://preview.redd.it/k5o0hrf1p1u41.jpg?auto=webp&s=e1a63e910289ddf1c240015e1bb40acb2b06feb6)
Today's pickup includes 20x 1mg Teva Klonopin. 18x .5 Solco/Qualitest Klonopin. 3x 30mg IR adderall by Teva. And 9x 20mg Adderall IR by Teva. N 17x 2mg Breckenridge pharma bars. 😳🤙🏻💯🤷♂️🤷♂️🤦♂️🙏🏻🙏🏻🙏🏻🙏🏻✌️✌️ :
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg?download=1)
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
![Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol | Business Wire Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol | Business Wire](https://mms.businesswire.com/media/20180212005322/en/640174/5/Boxes_With_Inhalers.jpg)